Effect of Tenapanor on Interdialytic Weight Gain in Patients on Hemodialysis

BACKGROUND AND OBJECTIVES: Interdialytic weight gain in patients on hemodialysis is associated with adverse cardiovascular outcomes and increased mortality. The degree of interdialytic weight gain is influenced by sodium intake. We evaluated the effects of tenapanor (AZD1722 and RDX5791), a minimall...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Clin J Am Soc Nephrol
Main Authors: Block, Geoffrey A., Rosenbaum, David P., Leonsson-Zachrisson, Maria, Stefansson, Bergur V., Rydén-Bergsten, Tina, Greasley, Peter J., Johansson, Susanne A., Knutsson, Mikael, Carlsson, Björn C.
Format: Artigo
Jezik:Inglês
Izdano: American Society of Nephrology 2016
Teme:
Original Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5012484/
https://ncbi.nlm.nih.gov/pubmed/27340281
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.09050815
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki